WIRB-Copernicus Group (WCG)

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Overcoming CMC challenges in cell and gene therapy: part II Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
  3. SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
  4. Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer Denis will be responsible for optimising global operations for the company
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

Related Content

Regulatory

WCG Clinical Services Division opens office in Japan

Its expanded presence in the Asia-Pacific region will strengthen its ability to support increasingly complex, global clinical trials
Finance

WIRB-Copernicus Group clinical services division acquires ACI Clinical

WCG Clinical Services Division expands portfolio to include specialist in endpoint adjudication and data monitoring safety committees
Regulatory

WCG expands portfolio to include drug safety solution provider

WIRB Copernicus Group (WCG) announced its acquisition of Vigilare International
Media

WCG’S MedAvante-ProPhase hires business leaders to grow and improve clinical trial data
Regulatory

New tool to better inform patients about clinical trials

WIRB-Copernicus Group, provider of solutions to measurably improve the quality and efficiency of clinical research has acquired Patient Genesis’ ConsentNow eConsent technology
Regulatory

WIRB-Copernicus Group celebrates IBC review milestone

WIRB-Copernicus IRB Group announced its IBC Services has achieved a major milestone in administering 4000 convened IBC meetings globally
Regulatory

WIRB-Copernicus Group acquires MedAvante and ProPhase

Names Jeffrey Litwin as the Chief Executive Officer (CEO) of the combined company
Subscribe now